Tilray's stock fell 4% on April 1, 2026, despite reporting record revenue for the third quarter. The decline highlights ongoing concerns about the company's financial performance and the broader cannabis sector's challenges.
- Tilray's stock fell 4% despite record Q3 revenue.
- Market concerns are focused on specific corporate performance issues.
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.
Share this article